α-Lipoic acid activates dimethylarginine dimethylaminohydrolase in cultured endothelial cells

Biochemical and Biophysical Research Communications

Volumn 398, Issue 4, 2010, Pages 653-658

  Lee, Woo Je ^a   Kim, Seung Hwan ^a   Kim, Geun Hyang ^a   Han, Sung Min ^a   Won, Jong Chul ^b   Jung, Chang Hee ^a   Park, Hye Sun ^a   Choi, Do Sook ^a   Lee, Ki Up ^a   Park, Joong Yeol ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

Lipoic acid; ADMA; DDAH; Endothelial cell; STAT3

Indexed keywords

DIMETHYLARGININASE; DIMETHYLARGININASE II; N(G),N(G) DIMETHYLARGININE; STAT3 PROTEIN; THIOCTIC ACID; UNCLASSIFIED DRUG;

AMINO ACID BLOOD LEVEL; ANIMAL CELL; ARTICLE; BINDING SITE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; MOLONEY MURINE SARCOMA ONCOVIRUS; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

AMIDOHYDROLASES; ANIMALS; ARGININE; CELL LINE, TUMOR; ENDOTHELIAL CELLS; ENZYME INDUCTION; MICE; PROMOTER REGIONS, GENETIC; STAT3 TRANSCRIPTION FACTOR; THIOCTIC ACID;

EID: 77955421440     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.127     Document Type: Article

References (30)

1. Duplain H., Burcelin R., Sartori C., Cook S., Egli M., Lepori M., Vollenweider P., Pedrazzini T., Nicod P., Thorens B., Scherrer U. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001, 104:342-345.
2. Huang P.L., Huang Z., Mashimo H., Bloch K.D., Moskowitz M.A., Bevan J.A., Fishman M.C. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995, 377:239-242.
3. Chan N.N., Chan J.C. Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?. Diabetologia 2002, 45:1609-1616.
4. Vallance P., Leiper J. Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1023-1030.
5. Ito A., Tsao P.S., Adimoolam S., Kimoto M., Ogawa T., Cooke J.P. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999, 99:3092-3095.
6. Lin K.Y., Ito A., Asagami T., Tsao P.S., Adimoolam S., Kimoto M., Tsuji H., Reaven G.M., Cooke J.P. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 2002, 106:987-992.
7. Kim M.S., Park J.Y., Namkoong C., Jang P.G., Ryu J.W., Song H.S., Yun J.Y., Namgoong I.S., Ha J., Park I.S., Lee I.K., Viollet B., Youn J.H., Lee H.K., Lee K.U. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat. Med. 2004, 10:727-733.
8. Lee W.J., Song K.H., Koh E.H., Won J.C., Kim H.S., Park H.S., Kim M.S., Kim S.W., Lee K.U., Park J.Y. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem. Biophys. Res. Commun. 2005, 332:885-891.
9. Lee W.J., Lee I.K., Kim H.S., Kim Y.M., Koh E.H., Won J.C., Han S.M., Kim M.S., Jo I., Oh G.T., Park I.S., Youn J.H., Park S.W., Lee K.U., Park J.Y. Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2488-2494.
10. Chang J.W., Lee E.K., Kim T.H., Min W.K., Chun S., Lee K.U., Kim S.B., Park J.S. Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: a pilot study. Am. J. Nephrol. 2007, 27:70-74.
11. Minokoshi Y., Kim Y.B., Peroni O.D., Fryer L.G., Muller C., Carling D., Kahn B.B. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002, 415:339-343.
12. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., Mu J., Foufelle F., Ferre P., Birnbaum M.J., Stuck B.J., Kahn B.B. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428:569-574.
13. Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem. J. 2006, 393:7-20.
14. Achan V., Tran C.T., Arrigoni F., Whitley G.S., Leiper J.M., Vallance P. all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase. Circ. Res. 2002, 90:764-769.
15. Boger R.H., Bode-Boger S.M., Szuba A., Tsao P.S., Chan J.R., Tangphao O., Blaschke T.F., Cooke J.P. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998, 98:1842-1847.
16. Loyaga-Rendon R.Y., Sakamoto S., Beppu M., Aso T., Ishizaka M., Takahashi R., Azuma H. Accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, attenuated dimethylarginine dimethylaminohydrolase activity and intimal hyperplasia in premenopausal human uterine arteries. Atherosclerosis 2005, 178:231-239.
17. Park K.G., Min A.K., Koh E.H., Kim H.S., Kim M.O., Park H.S., Kim Y.D., Yoon T.S., Jang B.K., Hwang J.S., Kim J.B., Choi H.S., Park J.Y., Lee I.K., Lee K.U. Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. Hepatology 2008, 48:1477-1486.
18. Leiper J.M., SantaMaria J., Chubb A., MacAllister R.J., Charles I.G., Whitley G.S., Vallance P. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem. J. 1999, 343(Pt. 1):209-214.
19. Matsuoka H., Itoh S., Kimoto M., Kohno K., Tamai O., Wada Y., Yasukawa H., Iwami G., Okuda S., Imaizumi T. Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension 1997, 29:242-247.
20. Paiva H., Laakso J., Laine H., Laaksonen R., Knuuti J., Raitakari O.T. Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia. J. Am. Coll. Cardiol. 2002, 40:1241-1247.
21. Takiuchi S., Fujii H., Kamide K., Horio T., Nakatani S., Hiuge A., Rakugi H., Ogihara T., Kawano Y. Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients. Am. J. Hypertens. 2004, 17:802-808.
22. MacAllister R.J., Parry H., Kimoto M., Ogawa T., Russell R.J., Hodson H., Whitley G.S., Vallance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br. J. Pharmacol. 1996, 119:1533-1540.
23. Jiang J.L., Li Ns N.S., Li Y.J., Deng H.W. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. Br. J. Pharmacol. 2002, 135:1175-1182.
24. Jiang J.L., Jiang D.J., Tang Y.H., Li N.S., Deng H.W., Li Y.J. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor. Acta Pharmacol. Sin. 2004, 25:893-901.
25. Tan B., Jiang D.J., Huang H., Jia S.J., Jiang J.L., Hu C.P., Li Y.J. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway. Vascul. Pharmacol. 2007, 46:338-345.
26. Hegyi K., Fulop K., Kovacs K., Toth S., Falus A. Leptin-induced signal transduction pathways. Cell Biol. Int. 2004, 28:159-169.
27. Burdelya L., Kujawski M., Niu G., Zhong B., Wang T., Zhang S., Kortylewski M., Shain K., Kay H., Djeu J., Dalton W., Pardoll D., Wei S., Yu H. Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects. J. Immunol. 2005, 174:3925-3931.
28. Inoue H., Ogawa W., Ozaki M., Haga S., Matsumoto M., Furukawa K., Hashimoto N., Kido Y., Mori T., Sakaue H., Teshigawara K., Jin S., Iguchi H., Hiramatsu R., LeRoith D., Takeda K., Akira S., Kasuga M. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat. Med. 2004, 10:168-174.
29. Matsukawa A., Kudo S., Maeda T., Numata K., Watanabe H., Takeda K., Akira S., Ito T. Stat3 in resident macrophages as a repressor protein of inflammatory response. J. Immunol. 2005, 175:3354-3359.
30. Zang Y., Yu L.F., Pang T., Fang L.P., Feng X., Wen T.Q., Nan F.J., Feng L.Y., Li J. AICAR induces astroglial differentiation of neural stem cells via activating the JAK/STAT3 pathway independently of AMP-activated protein kinase. J. Biol. Chem. 2008, 283:6201-6208.